Cargando…
MiR-105-3p acts as an oncogene to promote the proliferation and metastasis of breast cancer cells by targeting GOLIM4
BACKGROUND: Dysregulated miRNAs are involved in carcinogenesis of the breast and may be used as prognostic biomarkers and therapeutic targets during the cancer process. The purpose of this study was to explore the effect of miR-105-3p on the tumourigenicity of breast cancer and its underlying molecu...
Autores principales: | Lin, Bo, Liu, Chunhua, Shi, Enyi, Jin, Qiu, Zhao, Wenhui, Wang, Juan, Ji, Runyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962220/ https://www.ncbi.nlm.nih.gov/pubmed/33722196 http://dx.doi.org/10.1186/s12885-021-07909-2 |
Ejemplares similares
-
miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer
por: Li, Hao-Yi, et al.
Publicado: (2017) -
Circular RNA circ-NT5C2 acts as an oncogene in osteosarcoma proliferation and metastasis through targeting miR-448
por: Liu, Xunfa, et al.
Publicado: (2017) -
RBFOX2/GOLIM4 Splicing Axis Activates Vesicular Transport Pathway to Promote Nasopharyngeal Carcinogenesis
por: Luo, Chun‐Ling, et al.
Publicado: (2021) -
miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis
por: Wu, Gang, et al.
Publicado: (2014) -
MiR-588 acts as an oncogene in ovarian cancer and increases the radioresistance of ovarian cancer cells
por: Su, Xiaojuan, et al.
Publicado: (2023)